PKM2 has been seen to be a principally upregulated protein during urothelial tumor formation in the low-grade non-invasive pathway of human BC cell lines and tumors, establishing PKM2 overexpression in both low-grade non-invasive and high-grade invasive human BC. Here, PKM is linked to breast cancer.